10-Q: Sono-Tek Corporation Reports Mixed Results in Q2 2025, Backlog Hits Record High

Sono-Tek Corporation's Q2 2025 results show a decrease in net sales and operating income, but a record high backlog and growth in the clean energy and electronics sectors.

Summary

• Sono-Tek Corporation reported a decrease in net sales of 8% for the second quarter of fiscal year 2025, totaling $5.162 million, compared to $5.639 million in the same period last year.
• The company's gross profit decreased by 10% to $2.516 million, with a gross profit margin of 48.7%, down from 49.7% in the prior year.
• Operating income saw a significant decrease of 49%, falling to $286,000, primarily due to the decrease in gross profit.
• Despite these declines, the company's equipment-related backlog reached a record high of $11.472 million, a 7% increase year-over-year.
• The clean energy and electronics markets experienced substantial growth, increasing by 37% and 51%, respectively.
• Medical sales decreased significantly due to lower demand for stent and balloon coating systems, but balloon coating system sales are expected to recover in the second half of the year.
• For the first half of fiscal year 2025, net sales increased by 10% to $10.193 million, driven by strong sales in the alternative energy sector.
• The company's cash, cash equivalents, and marketable securities totaled $11.6 million as of August 31, 2024, with no outstanding debt.
• The company used $90,000 of cash in operating activities in the first half of fiscal 2025 compared to providing $1,107,000 in the first half of fiscal 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with strong growth in some sectors and a record backlog, but also significant declines in sales and profitability in the second quarter. The overall sentiment is neutral to slightly negative due to the mixed results.

Positives

• The company's backlog reached a record high, indicating strong future demand.
• The clean energy and electronics markets showed significant growth, demonstrating the company's success in these sectors.
• The company has a strong cash position with $11.6 million in cash, cash equivalents, and marketable securities.
• Net sales for the first half of fiscal 2025 increased by 10% compared to the same period last year.
• The company has no outstanding debt.

Negatives

• Net sales for the second quarter of fiscal 2025 decreased by 8% compared to the same period last year.
• Gross profit decreased by 10% in the second quarter of fiscal 2025.
• Operating income decreased by 49% in the second quarter of fiscal 2025.
• Medical sales declined significantly due to lower demand for stent and balloon coating systems.
• Industrial sales declined by 30% and 46%, respectively, for the second quarter of fiscal 2025 and the first half of fiscal 2025.
• The company used $90,000 of cash in operating activities in the first half of fiscal 2025 compared to providing $1,107,000 in the first half of fiscal 2024.

Risks

• The company's revenue can be highly variable from quarter to quarter due to the increased number and frequency of high Average Selling Price large platform machine orders.
• The medical market is experiencing lower demand for stent and balloon coating systems, which could impact future sales.
• The industrial market is experiencing a reduction in sales due to China-based competition.
• The company's sales in Asia and Latin America have decreased, which could impact overall revenue.
• The company's gross profit margin decreased due to product mix and the reallocation of labor expenses.

Future Outlook

The company expects balloon coating system sales to recover in the second half of the year. The company also anticipates continued growth in the clean energy and electronics markets. The company expects wide variations in both order flow and shipments from quarter to quarter.

Management Comments

• The company's move into the clean energy sector is showing transformative results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications.
• The company's product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices.
• The company has shifted its business from primarily selling ultrasonic nozzles and components to providing complete machine solutions and higher-value subsystems to original equipment manufacturers (OEMs).
• The company's comprehensive suite of thin film coating solutions and application consulting services ensures unparalleled results for clients.
• The company's growth strategy is focused on leveraging innovative technologies, proprietary know-how, unique talent and experience, and global reach.

Industry Context

The company's growth in the clean energy and electronics sectors aligns with broader industry trends towards renewable energy and advanced electronics manufacturing. The decrease in medical sales reflects a potential slowdown in that market, while the challenges in the industrial sector highlight the impact of global competition. The company's focus on complete machine solutions and higher-value subsystems is a strategic move to capture a larger share of the market and increase average selling prices.

Comparison to Industry Standards

• Sono-Tek's shift towards higher-value systems mirrors the strategy of companies like Applied Materials and Lam Research in the semiconductor equipment industry, which focus on providing comprehensive solutions rather than just components.
• The company's growth in the clean energy sector is comparable to the expansion seen by companies like First Solar and SunPower, which are benefiting from increased demand for renewable energy technologies.
• The decrease in medical sales is a trend also seen in some medical device companies, indicating a potential market slowdown or increased competition in that sector.
• The company's gross profit margin of 48.8% is within the range of other manufacturing companies in the industrial equipment sector, but the decrease in margin is a concern that needs to be addressed.
• The record backlog is a positive sign, but the variability in revenue from quarter to quarter is a challenge that is common in the capital equipment industry, similar to companies like ASML.

Stakeholder Impact

• Shareholders may be concerned about the decrease in sales and profitability in the second quarter, but encouraged by the record backlog and growth in key sectors.
• Employees may be affected by the company's performance and any potential changes in strategy.
• Customers in the clean energy and electronics sectors may benefit from the company's continued growth and innovation.
• Suppliers may be impacted by changes in the company's production and sales volumes.
• Creditors may be reassured by the company's strong cash position and lack of debt.

Next Steps

• The company will continue to focus on growing sales in the clean energy and electronics markets.
• The company will work to recover sales in the medical market.
• The company will address the challenges in the industrial market.
• The company will continue to expand its sales capabilities by increasing the size of its direct sales force and adding new distributors and sales representatives.

Key Dates

Keywords

ultrasonic coating systems, clean energy, electronics, medical devices, backlog, thin film coatings, semiconductor, solar, revenue, gross profit